NCT05070429

Brief Summary

The ACHIEVE Hearing Intervention Follow-Up study is a randomized trial of a telehealth versus conventional clinic-based hearing healthcare (HHC) delivery model among older adults who are existing hearing aid users to determine if a telehealth HHC model improves hearing aid use and other communication outcomes compared to clinic-based HHC.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
339

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Nov 2021

Longer than P75 for not_applicable

Geographic Reach
1 country

4 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

September 27, 2021

Completed
10 days until next milestone

First Posted

Study publicly available on registry

October 7, 2021

Completed
1 month until next milestone

Study Start

First participant enrolled

November 12, 2021

Completed
2.2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 10, 2024

Completed
1.1 years until next milestone

Results Posted

Study results publicly available

January 31, 2025

Completed
5 months until next milestone

Study Completion

Last participant's last visit for all outcomes

June 19, 2025

Completed
Last Updated

June 11, 2026

Status Verified

May 1, 2026

Enrollment Period

2.2 years

First QC Date

September 27, 2021

Results QC Date

January 2, 2025

Last Update Submit

May 18, 2026

Conditions

Keywords

hearing healthcaretelehealth hearing healthcareclinic-based hearing healthcarehearing healthcare service delivery models

Outcome Measures

Primary Outcomes (1)

  • Average Daily Hours of Hearing Aid Use

    Average daily hours of hearing aid use is obtained using objective hearing aid data logging. If a participant wears a hearing aid in both ears, then the ear with the greatest number of hours will be selected.

    Up to 1 year

Secondary Outcomes (3)

  • Treatment Satisfaction as Assessed by a Single Item From the International Outcome Inventory - Comprehensive Hearing Intervention (IOI-CHI) Scale

    1 year

  • Ability to Hear for Primary Communication Goal as Assessed by a Single Item From the Client-Oriented Scale of Improvement (COSI) Goals Achievement Questionnaire

    1 year

  • Hearing-specific Quality of Life as Assessed by the Hearing Handicap Inventory for the Elderly - Screening Version (HHIE-S) Questionnaire

    1 year

Other Outcomes (1)

  • Average Daily Hours of Hearing Aid Use Through Two Years of Follow-up

    Up to 2 years

Study Arms (2)

Conventional hearing healthcare group

OTHER

The conventional hearing healthcare group will have clinic-based visits every 6 months for the duration of the 2-year study. During Year 1, this group will receive clinic-based audiological rehabilitative service delivery and be able to use conventional options to address any unanticipated needs that arise, and then during Year 2, this group will also receive telehealth audiological rehabilitative service delivery and be able to utilize telehealth options, in addition to conventional options, to address any unanticipated needs that arise.

Other: Clinic-based audiological rehabilitative service deliveryOther: Telehealth audiological rehabilitative service delivery

Telehealth hearing healthcare group

OTHER

The telehealth hearing healthcare group will have clinic-based visits every 6 months for the duration of the 2-year study. This group will receive telehealth audiological rehabilitative service delivery and be able to utilize telehealth options, in addition to conventional options, to address any unanticipated needs that arise during both years of the study.

Other: Telehealth audiological rehabilitative service delivery

Interventions

Participants' scheduled clinic-based visits will be complemented with asynchronous and synchronous telehealth that will allow for routine troubleshooting of communication challenges, hearing aid technical issues, and reinforcement of self-management support strategies. At an initial session, participants will be instructed in the use of a study-provided, internet-enabled tablet device for telehealth sessions, re-introduced to the hearing loss toolkit for self-management and C2Hear Reusable Learning Objects within the context of the telehealth platform, re-evaluated on the Client Oriented Scale of Improvement (COSI) goals. Two remote follow-up sessions will be scheduled 3 and 6 weeks later to confirm participants' comfort with the telehealth platform and then completed every 6 months, in addition to scheduled 6-month clinic-based visits.

Also known as: Telehealth hearing healthcare
Conventional hearing healthcare groupTelehealth hearing healthcare group

Participants will have scheduled clinic-based visits at 6 and 12 months post-randomization to reinforce self-management strategies and perform hearing aid checks.

Also known as: Conventional hearing healthcare
Conventional hearing healthcare group

Eligibility Criteria

Age73 Years - 88 Years
Sexall
Healthy VolunteersNo
Age GroupsOlder Adult (65+)

You may qualify if:

  • Age 70-84 years
  • Community-dwelling, fluent English speaker
  • Availability of participant in area for study duration
  • Adult-onset hearing impairment, defined as four-frequency pure tone average (PTA, 0.5-4 kilohertz (kHz), better ear) ≥30 decibel (dB) hearing level (HL) (decibels hearing level) \& \<70 dB HL
  • Speech recognition scores in quiet ≥60% in better ear
  • Mini-Mental State Exam (MMSE) score ≥23 for participants with high school degree or less, or ≥25 for participants with some college education or more

You may not qualify if:

  • Reported disability in ≥2 activities of daily living (ADLs)
  • Vision impairment (worse than 20/63 on the Minnesota Near Vision Card)
  • Self-reported use of a hearing aid in the past 1 year
  • Medical contraindication to use of hearing aids (e.g., draining ear)
  • Unwilling to wear hearing aids on a daily basis
  • Conductive hearing impairment with air-bone gap \>15 dB in two or more contiguous frequencies in both ears

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (4)

Johns Hopkins Comstock Center for Public Health Research and Prevention

Hagerstown, Maryland, 21740, United States

Location

University of Minnesota

Minneapolis, Minnesota, 55415, United States

Location

University of Mississippi Medical Center

Jackson, Mississippi, 39216, United States

Location

Wake Forest University

Winston-Salem, North Carolina, 27104, United States

Location

MeSH Terms

Conditions

Hearing Loss

Condition Hierarchy (Ancestors)

Hearing DisordersEar DiseasesOtorhinolaryngologic DiseasesSensation DisordersNeurologic ManifestationsNervous System DiseasesSigns and SymptomsPathological Conditions, Signs and Symptoms

Results Point of Contact

Title
Lisa Gravens-Mueller, Biostatistician/Supervisor
Organization
University of North Carolina, Chapel Hill

Study Officials

  • Frank R Lin, MD, PhD

    Johns Hopkins University

    PRINCIPAL INVESTIGATOR
  • Victoria A Sanchez, AuD, PhD

    University of South Florida

    PRINCIPAL INVESTIGATOR

Publication Agreements

PI is Sponsor Employee
No
Restrictive Agreement
No

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
HEALTH SERVICES RESEARCH
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

September 27, 2021

First Posted

October 7, 2021

Study Start

November 12, 2021

Primary Completion

January 10, 2024

Study Completion

June 19, 2025

Last Updated

June 11, 2026

Results First Posted

January 31, 2025

Record last verified: 2026-05

Data Sharing

IPD Sharing
Will share

The ACHIEVE data coordinating center, in coordination with the Steering Committee and NIH, will prepare a public access data release that complies with prevailing NIH and HIPAA guidelines in place when the study has been completed. Any participant identifying information will be removed.

Shared Documents
STUDY PROTOCOL, SAP, ICF
Time Frame
We will share data 1 year following publication of the main results paper for the trial, unless NIH policy dictates that data be shared sooner.
Access Criteria
To be determined

Locations